South Dakota Investment Council Myriad Genetics Inc Transaction History

South Dakota Investment Council

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$19.92 - $31.6 $275,692 - $437,344	-13,840 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$22.08 - $47.08 $47,251 - $100,751	2,140 Added 18.29%	13,840 $396,000
Q1 2019 May 03, 2019	BUY	$26.93 - $34.7 $64,632 - $83,280	2,400 Added 25.81%	11,700 $388,000
Q4 2018 Feb 06, 2019	BUY	$27.23 - $45.56 $253,239 - $423,708	9,300 New	9,300 $270,000

254

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.23B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

Stay updated on South Dakota Investment Council with notifications on news.